Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 31;14(5):e0087523.
doi: 10.1128/mbio.00875-23. Epub 2023 Aug 25.

Activation of a Vibrio cholerae CBASS anti-phage system by quorum sensing and folate depletion

Affiliations

Activation of a Vibrio cholerae CBASS anti-phage system by quorum sensing and folate depletion

Geoffrey B Severin et al. mBio. .

Abstract

To counteract infection with phage, bacteria have evolved a myriad of molecular defense systems. Some of these systems initiate a process called abortive infection, in which the infected cell kills itself to prevent phage propagation. However, such systems must be inhibited in the absence of phage infection to prevent spurious death of the host. Here, we show that the cyclic oligonucleotide based anti-phage signaling system (CBASS) accomplishes this by sensing intracellular folate molecules and only expressing this system in a group. These results enhance our understanding of the evolution of the seventh Vibrio cholerae pandemic and more broadly how bacteria defend themselves against phage infection.

Keywords: CD-NTases; cyclic GMP-AMP; folate; phage; quorum sensing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
The VSP islands do not contribute to common V. cholerae biotyping phenotypes or virulence in a murine model of cholera. Differential biotyping phenotypes between classical O395, El Tor C6706, and C6706 VSP island mutants (ΔVSP-1, ΔVSP-2, and ΔVSP-1/2) demonstrating strain-specific (A) proteolysis of casein on milk agar, (B) hemolytic activity on blood agar, (C) growth on citrate minimal medium agar, (D) growth on matched LB and MacConkey agar plates, and (E) production of acetoin detected by Voges-Proskauer Assay. All images are representative of three independent experimental replicates. (F) In vivo competition between a 1:1 mixture of C6706 ΔVSP1/2 and C6706 ΔlacZ in an infant mouse model of cholera. Intestinal colony-forming units (CFUs) were enumerated using blue-white screening 20 h after oral gavage. N = 8 mice and statistical significance was determined using a one-sample t test and a hypothetical mean log10 C.I. = 0. The hypothetical mean is represented by a dotted line. The calculated mean log10 C.I. is represented by a solid line. ns = not significant.
Fig 2
Fig 2
VSP-1 encoded CBASS is responsible for V. cholerae biotype-specific SMX sensitivity. Twenty-four hours planktonic antibiotic sensitivity assays were performed in a variety of SMX concentration gradients. Heatmaps (A), (B), and (D) represent relative growth for each strain calculated using culture optical densities and the equation (OD600 SMX treatment/OD600 untreated) and reported as a color-coded mean % of N = 3 biological replicates. The IC50 for all strains in (A) are presented in Table S1. Scatter plots corresponding to (A), (B), and (D) are presented in (Fig. S2A through F). (C) Cartoon depiction of the VSP-1 genomic island. Dotted lines indicate partial VSP-1 truncations. Gray chevrons highlight the four gene VSP-1 CBASS operon. Numerals 1–5 indicate the location of a mutation identified in each of the five respective V. cholerae isolates found to have spontaneously evolved SMX resistance.
Fig 3
Fig 3
Culture density-dependent sensitivity to SMX reveals quorum sensing regulation of VSP-1 CBASS. (A) Growth curves (OD600, left y-axis) of WT C6706 and ΔcapV cultures treated without (+DMSO) and with 100 µg/mL SMX (+SMX). Intracellular cGAMP (µM, right y-axis) measured by UPLC-MS/MS in the SMX treated and untreated ΔcapV cultures. Growth curves of (B) quorum fluent ΔvpsL, (C) LCD-locked ΔvpsLΔhapR, and (D) HCD-locked ΔvpsLΔluxO cultures treated without (+DMSO) and with 100 µg/mL SMX (+SMX). Gray arrows indicate addition of 100 µg/mL SMX or DMSO. N = 3 biological replicates and error bars represent standard deviation. Statistical significance calculated using an unpaired T test with the Holm-Šídák method (*P < 0.05, **P < 0.005, ***P < 0.0005), n.s. = not significant.
Fig 4
Fig 4
QS regulates expression of V. cholerae CBASS. (A) Growth curve (OD600, left y-axis, solid line) of V. cholerae C6706 and the corresponding fold-change in transcript abundance (right-axis) of capV and dncV, relative to the initial 2 h time point, measured using RT-qPCR. N = 2 biological replicates and error bars represent standard deviation. (B) Relative transcript abundance of capV, dncV, and hapR measured by qRT-PCR in ΔcsqAΔluxS grown in the presence (+) and absence (−) of exogenous autoinducers (AIs). N = 3 biological replicates and error bars represent standard error of the mean. (C) % relative luminescence units of the indicated strains normalized to the mean lum/OD600 of ∆vpsLluxO maintaining the luminescent transcriptional reporter pPCBASS::lux. Population densities are low-cell density (LCD) and high-cell density (HCD). N = 3 biological replicates and error bars represent standard deviation. Statistical significance calculated using an unpaired t test with the Holm-Šídák method (*P < 0.05). This method was only used between strains at the same population density and the lack of graphical comparison indicates no statistical difference observed. (D) Relative luminescence (lum/OD600) of E. coli maintaining the luminescent transcriptional reporter pPCBASS::lux and the Ptac inducible hapR plasmid (pHapR) or a vector control (pVector2) grown in the presence of 6.25 µM IPTG. N = 3 biological replicates and error bars represent standard deviation. Statistical significance calculated using an unpaired t test with the Holm-Šídák method (**P < 0.005, ***P < 0.0005), n.s. = not significant. (E) Intracellular cGAMP measured using UPLC-MS/MS in the quorum fluent ΔcapV and LCD-locked ΔcapVΔcsqAΔluxS strains grown ~24 h in the presence of 100 µg/mL SMX. N = 4 biological replicates and error bars represent standard deviation. Statistical significance calculated using an unpaired t test (*P < 0.05).
Fig 5
Fig 5
HapR enhances VSP-1 mediated phage defense in E. coli. (A) Growth of E. coli containing either pHapR induced with 10 µM IPTG and pVSP-1 with their associated vector controls after overnight growth with T2 phage is shown as a mean percent of the uninfected culture from N = 3 biological replicates. mean % presented numerically and by heatmap for each condition. Scatter plot of data presented in Fig. S4. (B) Model of folate (by SMX) and QS (by HapR) regulation of CBASS activity and expression. At HCD, HapR induces transcription of the CBASS operon. Inhibition of folate biosynthesis by SMX alleviates the folate-dependent non-competitive inhibition of DncV leading to synthesis of cGAMP and activation of the phospholipase CapV. CBASS activity ultimately culminates in abortive infection that thwarts phage predation by limiting phage replication. Solid arrows and brakes indicate regulatory mechanisms that influence CBASS activity addressed in this study. Black hatched arrows and brakes indicate mechanisms known to contribute to CBASS activity but were not found to significantly contribute to QS or folate mechanisms illuminated in this study. Red brake represents a hypothesized phage-dependent disturbance in folates which is sensed by DncV to initiate abortive infection by the V. cholerae CBASS. Created with BioRender.com.

References

    1. Clemens JD, Nair GB, Ahmed T, Qadri F, Holmgren J. 2017. Cholera. Lancet 390:1539–1549. doi:10.1016/S0140-6736(17)30559-7 - DOI - PubMed
    1. Siddique AK, Cash R. 2014. Cholera outbreaks in the classical biotype era. Curr Top Microbiol Immunol 379:1–16. doi:10.1007/82_2013_361 - DOI - PubMed
    1. Hu D, Liu B, Feng L, Ding P, Guo X, Wang M, Cao B, Reeves PR, Wang L. 2016. Origins of the current seventh cholera pandemic. Proc Natl Acad Sci U S A 113:E7730–E7739. doi:10.1073/pnas.1608732113 - DOI - PMC - PubMed
    1. Son MS, Taylor RK. 2011. Genetic screens and biochemical assays to characterize Vibrio cholerae O1. Curr Protoc Microbiol. doi:10.1002/9780471729259.mc06a02s22 - DOI - PMC - PubMed
    1. Northrup RS, Doyle MA, Feeley JC. 1972. In vitro susceptibility of El Tor and classical Vibrio cholerae strains to trimethoprim and sulfamethoxazole. Antimicrob Agents Chemother 1:310–314. doi:10.1128/AAC.1.4.310 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources